IHS Chemical Week

Archives :: Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Displaying 221 - 240 of 1044 stories.
February 22, 2013
Drug companies looking for speedy turnaround and strong intellectual property (IP) protection for active pharmaceutical ingredient (API) production are moving away from low-cost...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Informex-2013-Bright-outlook-for-US-API-manufacturing_50011.html
February 22, 2013
DSM Pharmaceutical Products (Parsippany, NJ), the custom manufacturing and technology business of DSM, says it has signed a collaboration agreement with Chemtrix (Geleen, Netherlands)...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/DSM-and-Chemtrix-join-forces-for-continuous-flow-chemistry-in-API-manufacturing_50014.html
February 21, 2013
BASF says that it has signed an agreement with Bend Research (Bend, OR) to jointly evaluate and develop novel excipients to enhance the solubility and bioavailability of poorly soluble...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/BASF-and-Bend-Research-collaborate-to-improve-solubility-and-bioavailability-of-drugs_49992.html
February 20, 2013
IMCD (Rotterdam), a fast-growing distributor of specialty chemicals, pharma, and food ingredients, has acquired Indchem International (Mumbai), an established player in the Indian...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/IMCD-acquires-Indian-pharma-ingredients-distributor-Indchem-International_49963.html
February 19, 2013
Feature Pharma ingredients: Western manufacturers prepare for further expansion The active pharmaceutical ingredient industry will see further growth in the near term, and Western...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-19-February_49933.html
February 15, 2013
Cambrex (East Rutherford, NJ) and Dow Chemical have executed an agreement for Cambrex to contract manufacture Dow hydroxypropyl methylcellulose acetate succinate for drug solubility...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Dow-and-Cambrex-collaborate-to-manufacture-drug-solubility-solution_49893.html
February 14, 2013
Albany Molecular Research Inc. (AMRI; Albany, NY) and Codexis (Redwood City, CA) say that they have entered into a Smartsourcing partnership. AMRI launched Smartsourcing in April 2012...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/AMRI-and-Codexis-enter-into-technology-collaboration_49813.html
February 12, 2013
Teva’s API business reports rise in sales The active pharmaceutical ingredient (API) business of Teva Pharmaceutical (PetaŠł• Tiqwa, Israel), recorded a 2.5% increase in sales in...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-12-February_49761.html
February 8, 2013
Ampac Fine Chemicals (AFC; Rancho Cordova, CA), a subsidiary of American Pacific (Las Vegas), recorded an operating profit of about $1.3 million in its fiscal first quarter, ended 31...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Ampac-Fine-Chemicals-swings-to-profit_49706.html
February 7, 2013
Albemarle says it has started construction on an additional expansion of its Tyrone, PA fine chemical manufacturing facility. The company doubled the capacity for a proprietary...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Albemarle-announces-additional-expansion-of-fine-chemicals-site-in-Pennsylvania_49646.html
February 5, 2013
Johnson Matthey reports lower quarterly sales Johnson Matthey reported a 2% year-on-year decrease in group sales, excluding precious metals, to £635 million ($998 million), for...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-5-February_49583.html
February 4, 2013
ScinoPharm (Tainan, Taiwan) and Foresee Pharmaceuticals (Newark, DE) have signed a joint venture agreement under which they will develop injectable peptide drugs, starting with a...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/ScinoPharm-and-Foresee-Pharmaceuticals-to-form-drug-development-JV_49542.html
February 4, 2013
Aspen PharmaCare (Durban, South Africa) is in discussions with Merck Sharp Dohme (MSD; Darmstadt, Germany) regarding a possible acquisition of a Merck active pharmaceutical...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Aspen-Pharmacare-in-talks-for-Merck-API-facility-in-the-Netherlands_49535.html
February 4, 2013
Lonza says it plans to adapt the management structure of the company to focus on its target markets and to improve the effectiveness of its worldwide organizational structure and...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Lonza-restructures-management-team-businesses_49526.html
February 1, 2013
The active pharmaceutical ingredient (API) business segment of Perrigo (Allegan, MI) reported a 4.4% decrease in net sales, to $40.9 million in its fiscal second quarter ended 29...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Perrigos-API-activities-report-a-4-4-percent-year-on-year-drop-in-sales_49506.html
January 31, 2013
BASF says it has completed the previously announced acquisition of Pronova BioPharma (Lysaker, Norway), a pioneer in the fields of researching, developing, and manufacturing omega-3...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/BASF-completes-acquisition-of-Pronova-BioPharma_49465.html
January 30, 2013
Johnson Matthey reported a 2% year-on-year (YOY) decrease in group sales, excluding precious metals, to £635 million ($998 million), for its fiscal third quarter ended 31...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Johnson-Matthey-reports-lower-quarterly-sales_49439.html
January 29, 2013
Lonza reports rises in profits and sales Lonza recorded an 18.2% rise in net profits for 2012 compared with 2011, to 182 million Swiss francs ($196 million). Sales for 2012 increased...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-29-January_49408.html
January 24, 2013
Lonza recorded an 18.2% rise in net profits for 2012 compared with 2011, to 182 million Swiss francs ($196 million). Sales for 2012 increased 45.8%, to SF3.92 billion. In early 2012...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Lonza-reports-rises-in-profits-and-sales_49244.html
January 24, 2013
Blue Marble Biomaterials (Missoula, MT), has secured an exclusive distribution contract with Sigma Aldrich Fine Chemicals (SAFC; St Louis), the manufacturing and services business unit...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Blue-Marble-Biomaterials-secures-distribution-contract-with-SAFC_49255.html
Pages: « Previous  3 4 5 6 7 8 9 10 11 [12] 13 14 15 16 17 18 19 20 21 Next »










 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa